DYN Dyne Therapeutics, Inc.
DYN Dyne Therapeutics, Inc.
Healthcare · Biotechnology
Market read
Scan convergence 1 scan as of 2026-08-17 1 bull converging
POC $18.23 · VWAP $18.62 · +40.4% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
DYN Price Structure
Loading timeframes…
Peers
Every watchlist DYN belongs to, members best 30-day change first — DYN highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported EPS $-1.08 versus analyst consensus of $-0.75 (-44.3%).
full note →Against street estimates
How DYN's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
DYN research tape
20 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.